News
-
Doherty Institute researchers recipients of four NHMRC Research Excellence Awards
31 Mar 2022
-
Setting it Straight: Japanese Encephalitis part 2: the JEV, MVE, WNV/KV, YFV and dengue flaviviruses
28 Mar 2022
-
Recruitment commences for Phase 1 clinical trial of two Melbourne-made COVID-19 vaccines
25 Mar 2022
-
Doherty Institute secures landmark agreement with Moderna to expediate vaccine research for infectious diseases
24 Mar 2022
-
Vaccine-induced T cells provide long-lasting immune response to COVID-19
23 Mar 2022
-
Do we understand our decision making data?
22 Mar 2022
-
Researchers uncover how the immune systems works to target influenza B virus in Indigenous populations, potentially leading to hopes for universal, broad reaching flu vaccine
21 Mar 2022
-
Setting it Straight: Japanese Encephalitis part 1: arboviruses, togaviruses, flaviviruses and bunyaviruses
21 Mar 2022
-
Statement from the Doherty Institute
18 Mar 2022
-
How many Australians have had COVID-19?
18 Mar 2022